Lit Matters 3: Does the Amount of Contrast Given Affect Kidney Injury Rates?

Acute kidney injury after iodinated contrast is partly a dose phenomenon, especially in acute coronary syndrome patients heading to PCI. In this trial, lowering contrast volume reduced post-procedure AKI, while reinforcing a more practical ED point: order the contrasted study that answers the question, and avoid excess contrast when you can.

Contrast Volume and Kidney Injury

• Dose dependent AKI signal: Post-PCI kidney injury tracked with contrast burden, supporting the idea that contrast-associated AKI is not all-or-none but rises as exposure increases.
• Randomized ACS PCI trial: A 550-patient randomized trial in acute coronary syndromes, most with STEMI, tested automated contrast-volume reduction against usual manual injection practice.
• Primary AKI reduction: Using less contrast lowered AKI from 24.3% to 16% within 48 hours, a clinically meaningful drop in a population already vulnerable to renal hypoperfusion.
• Baseline kidney function matters: The benefit was concentrated in patients with eGFR below 60, while patients with better baseline renal function did not show a clear difference.
• How much contrast changed: The reduction strategy cut contrast use by about 41%, roughly 95 mL versus 160 mL, which helps anchor how procedure volume compares with a typical contrasted CT. We get into that comparison in the episode.
• Practical ED takeaway: Contrast can transiently worsen renal function, but the bigger error is skipping the right contrasted study; appropriateness first, then minimize avoidable volume when feasible.